Ces were embedded in optimal cutting temperature compound (OCT, Sakura Tissue-TekH, The Netherlands) and snap frozen in pre-chilled (280uC) n-hexane and stored at 280uC until used. Serial sections (8?0 mm thickness) were cut on a cryostat (Bright, UK), mounted onto poly-L-lysinecoated slides (VWR, UK) and allowed to dry for 2 hours at room temperature prior to immunofluorescent analysis as described below. To investigate the influence of horse age on the ability of tendon cells to resolve inflammation via this mechanism, we assessed the effect of IL-1b on FPR2/ALX expression in an order Enzastaurin Explant culture model. Explant tissues from normal tendons were grouped according to horse age as ,10 (n = 5) or 10 years of age (n = 8). 0.4 cm3 explants (300 mg 630 mg) were incubated at 37uC and 5 CO2 under humidified atmosphere in 3 23115181 ml of Dulbecco modified Eagle’s medium (PAA, UK) containing 1 Penicillin and Streptomycin without foetal calf serum. Samples were stimulated with 5 ngml-1 human recombinant IL-1b (Merck, CalbiochemH, UK) and non-stimulated (vehicle only) samples served as controls. At 72 hours after stimulation, explant tissues were embedded in OCT and snap frozen in chilled (280uC) nhexane, and cryosections cut as described above. Subsequently, consecutive cryosections were blocked in 5 normal goat serum (Sigma-Aldrich) in PBS for 1 hour in a humid chamber and probed with a 1:100 diluted mouse monoclonal antibody to FPR2/ALX (Lipoxin A4 receptor, IgG1, AbCam, UK) and secondary goat anti-mouse IgG1 (Southern Biotech, USA) each for 2 hours at room temperature. To visualise nuclei, slides were incubated with 0.5 mgml21 Hoechst 33342 (Invitrogen, UK) for 20 minutes and washed in PBS Tween-20H (PBS-T). To quench the background fluorescence, slides were incubated with 0.1 Sudan Black B (BDH, Poole, UK) in 70 ethanol for 20 minutes [59], washed in PBS-T and mounted under coverslips using a solution of 80 glycerol in 0.5 mM Tris buffer (pH 7.2). Slides were stored at 4uC in the dark until image acquisition. Cryosections of equine spleen were used as positive control tissue to validate suitability and dilution of antibodies for use on tendon sections. Negative controls consisted of spleen cryosections incubated with murine isotype matched primary control antibodies (Southern Biotech, USA) as previously reported [16]. To assess FPR2/ALX expression, images were Entrectinib site recorded using a Leica SP5 confocal microscope (Leica Microsystems, UK) as reported elsewhere [16].Measurement of LXA4 in Media from Explants Stimulated with IL-1b and PGEOur previous work has shown that stimulation of normal tendon explants with 5 ngml21 IL-1b or 1.0 mM PGE2 in vitro induced production of the pro-resolving ligand LXA4 which binds toProstaglandins and Lipoxins in TendinopathyFPR2/ALX [16]. In the current study, LXA4 levels in media were measured to ascertain if concurrent stimulation of macroscopically normal tendon explants with IL-1b (5 ngml21) and low (0.01 mM) or high dose (1.0 mM) PGE2 induced a dose-dependent increase in LXA4 levels. Tendon explants were derived from 3 horses aged between 9 and 14 years and LXA4 levels determined 24 hours after stimulation with the combination of pro-inflammatory mediators.analyse LXA4 release from tendon explants stimulated with proinflammatory mediators to account for effects of horse and experimental condition. In all cases, the P value was considered significant if below 0.05.Supporting InformationFigure S1 Prostaglandin E2 (PGE2).Ces were embedded in optimal cutting temperature compound (OCT, Sakura Tissue-TekH, The Netherlands) and snap frozen in pre-chilled (280uC) n-hexane and stored at 280uC until used. Serial sections (8?0 mm thickness) were cut on a cryostat (Bright, UK), mounted onto poly-L-lysinecoated slides (VWR, UK) and allowed to dry for 2 hours at room temperature prior to immunofluorescent analysis as described below. To investigate the influence of horse age on the ability of tendon cells to resolve inflammation via this mechanism, we assessed the effect of IL-1b on FPR2/ALX expression in an explant culture model. Explant tissues from normal tendons were grouped according to horse age as ,10 (n = 5) or 10 years of age (n = 8). 0.4 cm3 explants (300 mg 630 mg) were incubated at 37uC and 5 CO2 under humidified atmosphere in 3 23115181 ml of Dulbecco modified Eagle’s medium (PAA, UK) containing 1 Penicillin and Streptomycin without foetal calf serum. Samples were stimulated with 5 ngml-1 human recombinant IL-1b (Merck, CalbiochemH, UK) and non-stimulated (vehicle only) samples served as controls. At 72 hours after stimulation, explant tissues were embedded in OCT and snap frozen in chilled (280uC) nhexane, and cryosections cut as described above. Subsequently, consecutive cryosections were blocked in 5 normal goat serum (Sigma-Aldrich) in PBS for 1 hour in a humid chamber and probed with a 1:100 diluted mouse monoclonal antibody to FPR2/ALX (Lipoxin A4 receptor, IgG1, AbCam, UK) and secondary goat anti-mouse IgG1 (Southern Biotech, USA) each for 2 hours at room temperature. To visualise nuclei, slides were incubated with 0.5 mgml21 Hoechst 33342 (Invitrogen, UK) for 20 minutes and washed in PBS Tween-20H (PBS-T). To quench the background fluorescence, slides were incubated with 0.1 Sudan Black B (BDH, Poole, UK) in 70 ethanol for 20 minutes [59], washed in PBS-T and mounted under coverslips using a solution of 80 glycerol in 0.5 mM Tris buffer (pH 7.2). Slides were stored at 4uC in the dark until image acquisition. Cryosections of equine spleen were used as positive control tissue to validate suitability and dilution of antibodies for use on tendon sections. Negative controls consisted of spleen cryosections incubated with murine isotype matched primary control antibodies (Southern Biotech, USA) as previously reported [16]. To assess FPR2/ALX expression, images were recorded using a Leica SP5 confocal microscope (Leica Microsystems, UK) as reported elsewhere [16].Measurement of LXA4 in Media from Explants Stimulated with IL-1b and PGEOur previous work has shown that stimulation of normal tendon explants with 5 ngml21 IL-1b or 1.0 mM PGE2 in vitro induced production of the pro-resolving ligand LXA4 which binds toProstaglandins and Lipoxins in TendinopathyFPR2/ALX [16]. In the current study, LXA4 levels in media were measured to ascertain if concurrent stimulation of macroscopically normal tendon explants with IL-1b (5 ngml21) and low (0.01 mM) or high dose (1.0 mM) PGE2 induced a dose-dependent increase in LXA4 levels. Tendon explants were derived from 3 horses aged between 9 and 14 years and LXA4 levels determined 24 hours after stimulation with the combination of pro-inflammatory mediators.analyse LXA4 release from tendon explants stimulated with proinflammatory mediators to account for effects of horse and experimental condition. In all cases, the P value was considered significant if below 0.05.Supporting InformationFigure S1 Prostaglandin E2 (PGE2).
